Tuesday, July 7, 2026
Free · Stays on your device
Public Health - Medetomidine and Xylazine Consumer Protection Act
Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain …
Source: OpenStates · fetched April 13, 2026
Want updates?
Get notified when MD SB435 moves stage
Pick a channel below. Every option is opt-in, and we tell you exactly what we store.
We store your email address and the bill ID. We'll send a confirmation link first; alerts only start after you click it. Every email has a one-click unsubscribe.
Coming soon
- RSS feed· Atom 1.0 + JSON Feed per bill
- Bluesky· follow a CivicRadar bot post per status change
- Telegram· channel or DM via bot
- Discord· channel webhook
- WhatsApp· via WhatsApp Business
- SMS· via Twilio